LC-MS-MS method for the simultaneous determination of donepezil enantiomers in plasma

Chromatographia

Volumn 75, Issue 15-16, 2012, Pages 857-866

  Iordachescu, Adriana ^a,b   Silvestro, Luigi ^c   Tudoroniu, Ariana ^a   Savu, Simona Rizea ^c   Ciuca, Valentin ^a  

^a Pharma Serv Int'l SRL   (Romania)

^b UNIVERSITY OF BUCHAREST   (Romania)

^c 3S Pharmacological Consultation and Research GmbH   (Germany)

Author keywords

Chiral stationary phase; Donepezil; Enantiomers; HPLC; LC MS MS; Pharmacokinetic

Indexed keywords

ACETONITRILE; BICARBONATE; CELLULOSE TRIS(3,5 DIMETHYLPHENYLCARBAMATE); DONEPEZIL; SILICA GEL;

ACCURACY; AREA UNDER THE CURVE; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; DRUG ISOLATION; ELUTION; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MATERIAL COATING; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY;

EID: 84864671795     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1007/s10337-012-2292-7     Document Type: Article

References (21)

1. Gauthier S, Panisset M, Nalbantoglu J, Poirier J (1997) Can Med Assoc J 157:1047-1052
2. Sugimoto H, Yamanishi Y, Iimura Y, Kawakami Y (2000) Curr Med Chem 7(3):303-339
3. Sugimoto H, Ogura H, Arai Y, Iimura Y, Yamanishi Y (2002)Jpn J Pharmacol 89:7-20
4. Budhavari S (2001) Merck Index, 13th edn. Merck and Co. Inc. Whitehouse Station, 3453
5. Radwan MA, Abdine HH, Al-Quadeb BT, Aboul-Enein HY, Nakashima K (2006) J Chromatogr B Analyt Technol Biomed Life Sci 830(1):114-119
6. Eeckhaut AV, Michotte Y (2010) Pharmacological importance of chiral separations, chiral separations by capillary electrophoresis. Chromatographic science series, vol 100. CRC Press, Boca Raton
7. Haginaka J, Seyama C (1992) J Chromatogr 577(1):95-102
8. Matsui K, Oda Y, Nakata H, Yoshimura T (1999) J Chromatogr B Biomed Sci Appl 729(1-2):147-155
9. Abbas S, Fayez Y, Fattah A (2006) Chem Pharm Bull 54(10): 1447-1450
10. EMA-Guideline on the investigation of bioequivalence, Londra (2010) http://www.emea.europa.eu/docs/en-GB/document-library/Scientific-guideline/2010/ 01/WC500070039.pdf
11. Food and Drug Administration (May 2001) Guidance for Industry 436/Bioanalytical method validation
12. Tiseo PJ, Perdomo CA, Friedhoff LT (1998) Br J Clin Pharmacol 46:40-44
13. Viswanathan CT, Bansal S, Booth B, DeStefano AJ, Rose MJ, Sailstad J, PShah VP, Skelly JP, Swann PG, Weiner R (2007) Pharma Res 24(10):1962-1973
14. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Anal Chem 75:3019-3030
15. Kelly T, Gray TR, Huestis MA (2008) J Chromatrogr B Biomed Sci Appl 867(2):194-204
16. Nguyen LA, He H, Pham-Huy C (2006) IJBS 2:85-100
17. Berthod A (2010) Chiral recognition in separation methods. Mechanisms and applications. Springer, Berlin
18. Gübitz G, Schmid MG (2004) Chiral separation principles, chiral separations methods and protocols, methods in molecular biology. Humana Press, New Jersey
19. Beesley TE, Scott RPW (1998) Chiral chromatography. Separation science series, Wiley, New York
20. Tiseo PJ, Rogers SL, Friedhoff LT (1998) Br J Clin Pharmacol 46:13-18
21. Rogers SL, Friedhoff LT (1998) Br J Clin Pharmacol 46:1-6